The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticlesFull Access

A Reduction in Health Care Expenditures Linked to Mental Health Service Use Among Adults With Chronic Physical Conditions

Abstract

Objective:

The aim was to examine the impact of receipt of mental health services on health care expenditures for U.S. adults with major chronic physical conditions.

Methods:

Medical Expenditure Panel Survey data for 2004–2014 were analyzed for adults ages ≥18 with at least one of six chronic physical conditions (cardiovascular diseases, cancer, diabetes, emphysema, asthma, and arthritis) who were followed up for 2 years (N=33,419). Outcomes included overall health care spending and expenditure by service type (inpatient services, outpatient services, emergency department visits, office-based physician visits, and prescribed medication). A difference-in-differences model compared a change in health care costs in the subsequent year for those who did and did not receive mental health services in the preceding year.

Results:

On average, the increase in overall health care expenditure in the subsequent year among adults receiving mental health services in the preceding year was smaller by 12.6 percentage points (p<0.05) than for those who did not receive such services. The difference was equivalent to $1,146 in 2014 constant U.S. dollars (p=0.05). Medication treatment alone did not have a meaningful effect on overall costs. The combination of psychotherapy and medication was associated with a per-capita reduction in overall health care expenditure of 21.7 percentage points, or $2,690 (p<0.01). The combination was also associated with reduced costs for office-based visits (p<0.05) and medication (p<0.05).

Conclusions:

Receipt of mental health services was associated with a reduction in overall health care costs, particularly for office-based visits and prescribed medication, among adults with chronic physical conditions.

HIGHLIGHTS

  • Among adults with at least one of six major chronic physical conditions (cardiovascular disease, cancer, diabetes, emphysema, asthma, or arthritis), those who received any mental health services in the preceding year had a smaller increase in overall health care expenditure in the subsequent year.

  • Receipt of both psychotherapy and medication treatment was associated with a greater reduction in health care costs, compared with receipt of only one of the services.

  • Receipt of mental health services in the preceding year led to a reduction in health care expenditures for office-based visits and prescribed medication in the subsequent year.

Cardiovascular disease (CVD), cancer, diabetes, chronic lower-respiratory diseases, and arthritis are among the leading causes of mortality and disability among American adults (1, 2). These conditions have posed a significant financial burden of hundreds of billions of U.S. dollars each year to both patients and the health care system (37). Among individuals with these chronic physical conditions, mental disorders, such as affective disorders and anxiety, are also prevalent as a result of coping with physical symptoms (815). The co-occurrence of mental health problems among patients with these chronic physical conditions could reduce adherence to treatment, decrease quality of life (1619), and increase health care costs (20, 21).

The vast literature on how mental health service use influences health care expenditures of individuals with physical conditions focuses on how depression treatment is associated with medical costs of people with concurrent depression. Some found that total health care expenditure was reduced by treatment with antidepressants and psychotherapy (22, 23), yet others showed that receiving depression treatment was associated with increased costs (24) or no differences in costs (25). Furthermore, mental health conditions are often underdiagnosed and overlooked among individuals with complex chronic physical conditions (26, 27). A recent study of U.S. adults ages 18 and older found that having adverse physical health events altered demand for mental health services (28), which could have implications on overall health care utilization and cost over time.

To our knowledge, little research has quantified the impact of receipt of mental health services on health care expenditures in a large population sample of people with chronic physical conditions that are often comorbid with various mental health conditions. Our primary objective was to examine how the utilization of mental health services in the preceding year was associated with the change in overall health care expenditure in the subsequent year among individuals with at least one of six chronic physical conditions: CVD, cancer, diabetes, emphysema, asthma, and arthritis. We also analyzed the relationship between receipt of each type of mental health service and overall health care expenditure. Moreover, we examined the impact of mental health service use on service-level costs, including inpatient services, outpatient services, emergency department (ED) visits, office-based physician visits, and prescribed medication.

Methods

Data and Sample

We used data from the Household Component of the Medical Expenditure Panel Survey (MEPS) for years 2004 to 2014 (29). MEPS is a large-scale survey of a nationally representative sample of the noninstitutionalized population in the United States (29). The panel design of the MEPS allowed us to follow each individual in each of the 10 panels (2004–2014) for 2 calendar years and thus to examine how receipt of mental health services in the preceding year was associated with health care expenditures in the subsequent year.

The study population consisted of adults ages 18 and older who reported diagnoses of any of six physical conditions: CVD (i.e., heart disease and stroke), cancer, diabetes, emphysema, asthma, and arthritis. We derived our sample on the basis of the MEPS questions about whether an individual had ever been diagnosed as having each of the six physical conditions either before or during the first year of follow-up (30). Among 36,480 individuals who met the criteria, we excluded 3,061 persons (8.4%) who reported zero overall health care spending during a year, which is uncommon among adults with these physical conditions. Having zero health care spending may be due to self-report bias, or these persons may have had different characteristics compared with others in the sample. The analytic sample included 33,419 adults with any of the six physical conditions, of whom 7,929 had a diagnosis of co-occurring mental disorders, such as anxiety, mood disorders, adjustment disorders, schizophrenia, and other psychotic disorders.

Outcome Variable

Our primary outcome was overall health care expenditure, which captured the overall payment from all sources for health care services used within a year. We also analyzed service-level costs, separately for inpatient services, outpatient services, ED visits, office-based physician visits, and prescribed medication. Health care expenditures were adjusted for inflation by the Personal Healthcare (overall and component) Price Indices and Consumer Price Index (for medication) (31) and expressed in 2014 constant dollars.

Outpatient Mental Health Services

Mental health services included psychotherapy and medication treatment. Psychotherapy was defined as seeing a psychologist or as receipt of psychotherapy or mental health counseling during an office-based physician visit, outpatient visit, or ED visit. Medication treatment for mental health was identified by purchases of prescription drugs associated with psychiatric conditions. Information on type of provider (i.e., psychologist) and visit category (i.e., psychotherapy or mental health counseling) in MEPS medical event files was used to determine psychotherapy use. We used clinical classification codes 650 (adjustment disorders), 651 (anxiety disorders), 657 (mood disorders), and 659 (schizophrenia and other psychotic disorders) to identify prescription drug purchases associated with mental disorders (a table with a complete list of ICD-9-CM codes associated with the clinical classification codes is included in an online supplement to this article). Most common medications associated with these clinical classification codes included selective serotonin reuptake inhibitors, selective serotonin and norepinephrine reuptake inhibitors, antidepressants, antipsychotics, and anxiolytic or sedative drugs.

Covariates

Individual demographic and socioeconomic characteristics included age, sex, race-ethnicity, marital status, census region, metropolitan residence, income, education, and insurance status. Because the utilization of mental health services could depend on the severity of physical illness as well as the need for mental health care, we controlled for perceived physical and mental health status as proxy for the severity of physical and mental health conditions, respectively. Our measures included physical component summary and mental component summary scores that were computed with information from the 12-item Short-Form Health Survey (32). Co-occurrence of mental disorders and alcohol or drug use disorders was identified with clinical classification codes from the MEPS household condition files.

Analytic Model

The identification of the effect of receiving mental health services on subsequent health care expenditures hinged on a difference-in-differences (DID) framework. We compared an average change in health care expenditures from the preceding year to the subsequent year among individuals with the chronic conditions who utilized mental health services in the preceding year to an average change in health care expenditures among those who did not.

Although overall health care expenditure did not have zero value, it was distributed highly right-skewed with individuals who had extremely high cost. To obtain more consistent parameter estimates, we employed a generalized linear model (GLM) with the log link function and the gamma distribution (33). We included interaction terms for the indicators of receipt of mental health services in the preceding year and the indicator of the subsequent year in our models. The coefficients on the interaction terms measured the percentage point changes in health care expenditure in the subsequent year attributed to receipt of mental health services in the preceding year.

We then examined the effects on health care expenditures of receiving mental health services by type of service using two-part DID models (3335), because service-level costs may be right-skewed and could also have many zeros (e.g., patients who did not have any hospital admissions or ED visits). In this approach, the first part estimated the impact of receiving mental health services on the probability of incurring any cost by using logistic regression and the second part modeled the change in expenditures among those who had nonzero costs by using GLM.

All models controlled for annual individual demographic and socioeconomic characteristics, perceived health status, co-occurrence of mental disorders and alcohol or drug use disorders, and time trend. We computed the average marginal effects of the interaction terms in terms of dollar amounts to estimate the change in health care expenditures associated with use of mental health services. Bootstrapped standard errors of the marginal interaction effects were obtained based on 1,000 repetitions.

Although our models included different sociodemographic characteristics and time trend, selection bias might still be present because of potential unobserved person heterogeneity. To mitigate this concern, we adjusted our estimates with inverse-probability weights to better balance baseline characteristics of the two comparison groups (i.e., those who used mental health services and those who did not). A properly reweighted inverse-probability–weighted estimator is largely used in treatment effect estimation as a tool for causal inference to adjust for measured confounders (36, 37). Further, an inverse-probability–weighted DID estimator has a doubly robust property because it adjusts estimates for both observed and unobserved selection (38, 39). We obtained inverse-probability weights by fitting a logistic regression of the indicator of receipt of any mental health services on all the covariates above, as well as smoking status and year dummies. Our analyses used Stata software, version 13.1 (40). Because we used publicly available MEPS data sets, review by an institutional review board was waived.

For a sensitivity analysis, we estimated linear regression models with and without a log-transformation of expenditures to check the robustness of our results. We also applied survey weights in MEPS and excluded outlier observations.

Results

Characteristics of the Study Population

Table 1 summarizes characteristics of the study sample in the preceding year, for the entire sample and by use of mental health services. The mean overall health care expenditure in the preceding year among individuals with at least one of the six physical conditions was $9,067. Among the 33,419 persons in the overall sample, 20.1% received mental health services. The second and third columns present characteristics of two groups without inverse-probability weighting. Among those who used mental health services, 8.5% received psychotherapy only, 71.5% received medication treatment only, and 20% received a combination of both. The mean overall health care expenditure among individuals who received any mental health services was $13,141, which was higher than the average cost of $8,043 among those who did not use mental health services.

TABLE 1. Characteristics of adults with chronic physical conditions who did and did not receive mental health care in the preceding year, with and without inverse-probability weightsa

Received mental health care (unweighted)Received mental health care (weighted)
VariableTotal sample (N=33,419)Yes (N=6,715)No (N=26,704)YesNo
Outcome: overall health care expenditure (M±SD)$9,067.3±$17,548.7$13,141.0±$21,320.3$8,042.9±$16,306.0$14,823.5±$21,813.2$8,505.2±$13,354.3
Explanatory
 Any mental health service use in the preceding yearb20.1100.00100.00
  Psychotherapy only1.78.503.00
  Medication treatment only14.471.5061.70
  Psychotherapy plus medication treatment4.020.0020.30
Control
 Health status
  Physical component  summary score  (M±SD)c42.5±12.439.3±12.943.2±12.136.1±12.739.9±13.3
  Mental component  summary score  (M±SD)c48.9±11.241.6±12.350.7±10.138.0±12.640.8±12.1
 Chronic physical condition
  Cardiovascular  disease34.939.033.841.338.7
  Cancer18.318.618.320.017.8
  Diabetes27.125.127.625.123.5
  Emphysema or  asthma24.932.123.135.334.6
  Arthritis58.567.356.375.364.9
 Mental disorder23.795.05.8100.094.9
 Alcohol or drug use  disorder.81.9.52.51.9
 Age (M±SD)56.9±16.155.0±14.957.4±16.455.5±13.353.5±14.8
 Female60.871.758.076.173.0
 Race-ethnicity
  White77.169.356.180.770.3
  Asian4.01.54.7.61.6
  Black2.014.521.78.813.9
  Other1.31.31.31.11.2
  Hispanic15.613.416.28.813.0
 Marital status
  Single14.534.914.213.718.0
  Married53.346.055.146.442.4
  Widowed13.112.013.410.912.0
  Divorced15.52.114.124.722.6
  Separated3.65.03.24.35.0
 Family income
  Poor18.224.416.825.425.9
  Near poor6.37.46.08.86.4
  Low income15.915.915.916.315.5
  Middle income28.826.829.225.427.1
  High income30.825.532.124.125.1
 Census region
  West57.820.723.116.723.3
  South3.939.239.044.736.2
  Midwest22.023.321.719.623.9
  Northeast16.316.816.219.016.6
 Metropolitan72.469.973.068.371.8
 Employed46.237.748.327.940.0
 Education
  Less than high school23.723.323.823.021.0
  High school31.232.131.031.230.1
  College36.537.036.438.540.3
  Graduate school8.67.68.87.38.6
 Insurance coverage
  Private58.652.360.248.953.4
  Public32.640.130.746.838.3
  Uninsured8.86.36.93.87.1

aValues are percentages unless otherwise indicated. Inverse-probability weights were estimated from a logistic regression for the indicator of receiving any mental health services as a function of all covariates, smoking status, and year dummies.

bPsychotherapy was defined as seeing a psychologist or as receipt of psychotherapy or mental health counseling during an office-based physician visit, outpatient visit, or emergency department visit. Medication treatment for mental health was identified by purchases of prescription drugs associated with psychiatric conditions (i.e., adjustment disorders, anxiety, mood disorders, schizophrenia, and other psychotic disorders).

cPossible physical and mental component summary scores range from 0 to 100, with higher scores indicating better self-perceived health status.

TABLE 1. Characteristics of adults with chronic physical conditions who did and did not receive mental health care in the preceding year, with and without inverse-probability weightsa

Enlarge table

In the sample, 35% had CVD and 18% had cancer. The proportions of individuals who had diabetes or who had emphysema or asthma were 27% and 25%, respectively; 59% had arthritis. A total of 7,929 individuals (23.7%) reported that they had been diagnosed as having a mental disorder. As measured by the physical component summary score, those who received mental health services had poorer self-perceived health status, compared with those who did not receive mental health services. Among those who received mental health services, 95% reported that they had mental disorders. Six percent of those who did not receive mental health services reported that they had mental disorders. Compared with those who did not receive mental health services, those who received services had a higher proportion of co-occurring alcohol or drug use disorders (1.9% versus 0.5%). Compared with those who did not receive mental health services, those who did were more likely to be female, White, and poor and less likely to be married and employed.

The fourth and fifth columns of Table 1 present characteristics of the two groups with use of inverse-probability weights. After weighting, the two groups became more balanced in observed characteristics, especially perceived mental health status (mental component summary score), co-occurrence of mental and alcohol or drug use disorders, marital status, and family income.

Table 2 reports mean health care expenditures, total and by type of service. The increase in overall expenditure was greater among individuals who did not use mental health services (an increase from $8,043 to $8,624), compared with the increase in expenditure of those receiving mental health services (an increase from $13,141 to $13,295). Similar patterns were observed for inpatient expenditure and prescribed medication cost. Average ED expenditure slightly decreased in both groups. Office-based provider cost and outpatient cost slightly decreased among those using mental health services, but these costs increased among individuals who did not use mental health services.

TABLE 2. Mean health care expenditures (in 2014 constant dollars) for adults with chronic physical conditions, by receipt of mental health services in the preceding year

Received mental health care
Total sample (N=33,419)Yes (N=6,715)No (N=26,704)
Expenditure type and yearMSDMSDMSD
Overall
 1st year9,067.319,562.713,141.021,320.38,042.916,306.0
 2nd year9,562.618,224.013,294.720,597.18,624.117,452.3
Inpatient services
 1st year2,663.112,808.93,535.515,162.82,443.712,135.9
 2nd year2,861.412,787.13,660.714,268.72,660.412,378.9
Emergency department visits
 1st year307.21,480.4391.21,554.8286.11,460.4
 2nd year292.21,245.1376.91,424.5270.91,194.8
Office-based physician visits
 1st year2,072.45,518.42,886.55,712.01,867.75,449.6
 2nd year2,134.65,483.52,836.55,795.41,958.15,388.0
Outpatient services
 1st year784.03,599.81,063.94,112.7713.53,455.4
 2nd year790.13,988.7946.73,387.2750.74,125.3
Prescribed medication
 1st year2,338.64,840.64,007.97,546.61,918.83,758.6
 2nd year2,550.35,095.94,156.16,756.12,146.64,495.6

TABLE 2. Mean health care expenditures (in 2014 constant dollars) for adults with chronic physical conditions, by receipt of mental health services in the preceding year

Enlarge table

Table 3 presents coefficient estimates from our GLM models for overall health care expenditure. Model 1 estimated change in overall cost associated with receiving any mental health services, and model 2 estimated change in overall cost associated with types of mental health services. In model 1, the increase in expenditure in the subsequent year among individuals who received any mental health services was smaller than the increase in expenditure among those who did not receive these services—by 12.6 percentage points (p<0.05). Model 2 suggests that receiving a combination of psychotherapy and medication treatment reduced the increase in subsequent overall cost by 21.7 percentage points (p<0.01).

TABLE 3. Coefficients from generalized linear models examining the impact of receipt of mental health services in a preceding year on overall expenditures in the subsequent year for adults with chronic physical conditionsa

Model 1Model 2
VariableCoefficientSECoefficientSE
Explanatory
 Receipt of mental health care in the preceding year (reference: no receipt)b
  Any mental health services.456***.045nana
  Psychotherapy onlynana.303***.091
  Medication treatment onlynana.366***.046
  Psychotherapy plus medication treatmentnana.724***.058
 Subsequent year.111.057.112.058
 Interaction term of receipt of mental health care and subsequent year
  Any mental health services × subsequent year–.126*.062nana
  Psychotherapy × subsequent yearnana–.231.132
  Medication treatment × subsequent yearnana–.077.064
  Psychotherapy plus medication treatment × subsequent yearnana–.217**.076
Control
 Health status
  Physical component summary score–.031***.001–.031***.001
  Mental component summary score–.006***.001–.004***.001
 Chronic physical condition (reference: no indicated condition)
  Cardiovascular diseases.216***.026.231***.026
  Cancer.235***.031.236***.031
  Diabetes.298***.027.296***.027
  Emphysema or asthma.068*.026.061*.026
  Arthritis.007**.029.004.029
 Mental disorder (reference: no disorder)–.101**.032–.085**.032
 Alcohol or drug use disorder (reference: no disorder).423***.079.384***.078
 Age.005***.001.006***.001
 Female (reference: male).013.027.008.027
 Race-ethnicity (reference: White)
  Asian–.208.122–.179.128
  Black.146***.038.153***.039
  Other race.257*.115.273*.115
  Hispanic–.007.040–.003.040
 Marital status (reference: single)
  Married–.162***.041–.142***.042
  Widowed–.163**.051–.152**.052
  Divorced–.119**.043–.118**.043
  Separated–.134*.065–.132*.066
 Family income (reference: poor)
  Near poor.128**.044.132**.044
  Low income.045.043.048.043
  Middle income.115**.040.124**.039
  High income.220***.045.225***.045
 Census region (reference: West)
  South–.091*.036–.075*.035
  Midwest.013.037.015.037
  Northeast.050.041.030.040
 Metropolitan (reference: not metropolitan).064*.028.058*.028
 Employed (reference: not employed)–.123***.034–.101**.033
 Education (reference: less than or some middle school)
  High school.015.034.014.034
  College.119***.036.099**.036
  Graduate school.298***.055.238***.053
 Insurance coverage (reference: uninsured)
  Private.753***.060.760***.058
  Public.579***.059.579***.057
 Constant9.352***.1289.228***.129

aAll estimates were adjusted for year dummies and inverse-probability weights. Model 1 estimated change in overall cost associated with receiving any mental health services, and model 2 estimated change in overall cost associated with types of mental health services (na, not applicable).

bPsychotherapy was defined as seeing a psychologist or as receipt of psychotherapy or mental health counseling during an office-based physician visit, outpatient visit, or emergency department visit. Medication treatment for mental health was identified by purchases of prescription drugs associated with psychiatric conditions (i.e., adjustment disorders, anxiety, mood disorders, schizophrenia, and other psychotic disorders).

*p<.05, **p<.01, ***p<.001.

TABLE 3. Coefficients from generalized linear models examining the impact of receipt of mental health services in a preceding year on overall expenditures in the subsequent year for adults with chronic physical conditionsa

Enlarge table

Table 4 presents results from two-part DID models used to estimate the impact of mental health service use on service-level costs. We did not find a statistically significant relationship of mental health service use and subsequent inpatient cost, ED cost, or outpatient cost. Although use of mental health services did not reduce the probabilities of incurring costs for office-based visits and prescribed medication, it was associated with a reduction in costs. Utilization of any mental health services lowered the subsequent cost increase for office-based visits by 15.7 percentage points (p<0.05) and for prescribed medication by 17.7 percentage points (p<0.05). Receiving a combination of both psychotherapy and medication treatment lowered the cost increase for office-based visits and prescribed medication by 33.3 percentage points (p<0.001) and 22.7 percentage points (p<0.05), respectively.

TABLE 4. Change in health care expenditures associated with mental health service use among adults with chronic physical conditions, by type of service useda

Change in health care expenditures (%)b
Any mental health servicesPsychotherapy onlyMedication treatment onlyPsychotherapy plus medication treatment
Service typeCoefficientSECoefficientSECoefficientSECoefficientSE
Inpatient services
 Change in probability of incurring cost–1.26.016–.15.036–.99.016–2.30.021
 Change in cost among those with nonzero cost4.92.123–12.0.2767.16.126–1.75.161
Emergency department visits
 Change in probability of incurring cost.03.017–4.87.042.83.018–1.65.021
 Change in cost among those with nonzero cost13.20.129–29.0.27710.70.13725.30.155
Office-based visits
 Change in probability of incurring cost–3.74***.011–6.20***.019–3.48**.012–3.84***.011
 Change in cost among those with nonzero cost–15.70*.079–42.20*.175–5.60.082–33.30***.093
Outpatient services
 Change in probability of incurring cost–.39.0211.75.05.14.021–2.38.028
 Change in cost among those with nonzero cost–7.16.142–30.30.422–3.54.143–12.80.195
Prescribed medication
 Change in probability of incurring cost–1.89*.009–.02.022–2.28*.009–1.62.01
 Change in cost among those with nonzero cost–17.70*.077–2.65.20–15.80*.077–22.70*.09

aReference group, adults who did not use mental health services. Two-part difference-in-differences models were used to estimate changes in service-level costs (i.e., inpatient services, emergency department visits, office-based visits, outpatient services, and prescribed medication). Changes in probability of incurring any cost are marginal effects estimated from logistic regression in the first part with bootstrapped SEs from 1,000 repetitions. Changes in cost among those with nonzero cost are coefficients from the generalized linear model in the second part that applied to a subsample of patients who had incurred any expenditure.

bPsychotherapy was defined as seeing a psychologist or as receipt of psychotherapy or mental health counseling during an office-based physician visit, outpatient visit, or emergency department visit. Medication treatment for mental health was identified by purchases of prescription drugs associated with psychiatric conditions (i.e., adjustment disorders, anxiety, mood disorders, schizophrenia, and other psychotic disorders).

*p<.05, **p<.01, ***p<.001.

TABLE 4. Change in health care expenditures associated with mental health service use among adults with chronic physical conditions, by type of service useda

Enlarge table

Table 5 presents changes in health care expenditures associated with use of mental health services in terms of dollar amounts (2014 constant dollars). On average, adults who received any mental health services had a cost saving in the subsequent year of $1,146, compared with those who did not use mental health services. Receipt of both psychotherapy and medication treatment was associated with savings in overall cost, office-based visit cost, and prescribed medication cost of $2,690, $1,056, and $577, respectively.

TABLE 5. Change (in 2014 constant dollars) in health care expenditures (overall and by type of service used) associated with mental health service use among adults with chronic physical conditionsa

Overall expenditureInpatient servicesEmergency department servicesOffice-based visitsOutpatient servicesPrescribed medication
Service typebME95% CIME95% CIME95% CIME95% CIME95% CIME95% CI
Any mental health services–1,146.3–2,327.3, 34.6–81.3–1,031.7, 869.043.2–49.8, 136.2–371.0*–691.4, –50.7–85.4–361.2, 190.3–335.6–698.8, 27.6
Psychotherapy only–2,238.0–4,838.9, 362.8–327.5–2,247.6, 1,592.5–160.1–401.5, 81.4–1,371.3*–2,484.8, –257.8–278.2–1,237.5, 681.221.7–984.9, 1,028.2
Medication treatment only–560.9–1,794.1, 672.255.4–978.9, 1,089.748.3–50.6, 147.4–126.0–464.5, 212.5–30.4–302.5, 241.8–271.1–658.7, 116.5
Psychotherapy plus medication treatment–2,690.1**–4,600.9, –779.3–486.6–1,823.0, 849.754.7–58.6, 168.0–1,055.8***–1,614.3, –497.3–234.2–747.6, 279.3–577.4–1,330.4, 175.7

aReference group, adults who did not use mental health services. Changes in overall expenditures are marginal effects (ME) estimated from generalized linear models. For service-level costs (inpatient services, emergency department services, office-based physician visits, outpatient services, and prescribed medication), changes in expenditures are marginal effects estimated by combining results from two parts of the two-part difference-in-differences models. Bootstrapped 95% CI based on 1,000 repetitions.

bPsychotherapy was defined as seeing a psychologist or as receipt of psychotherapy or mental health counseling during an office-based physician visit, outpatient visit, or emergency department visit. Medication treatment for mental health was identified by purchases of prescription drugs associated with psychiatric conditions (i.e., adjustment disorders, anxiety, mood disorders, schizophrenia, and other psychotic disorders).

*p<.05, **p<.01, ***p<.001.

TABLE 5. Change (in 2014 constant dollars) in health care expenditures (overall and by type of service used) associated with mental health service use among adults with chronic physical conditionsa

Enlarge table

Sensitivity analyses using linear regression models with and without log-transformed expenditures, with exclusion of outliers, or adjusting the estimates with survey weights yielded consistent results.

Discussion

Our findings suggest that receipt of mental health services may subsequently lead to savings in overall health care cost among adults with any of six prevalent chronic physical conditions, i.e., CVD, cancer, diabetes, emphysema, asthma, or arthritis. Use of mental health services in the preceding year was significantly associated with a reduction in subsequent overall health care expenditure by 12.6 percentage points. The average saving was estimated to be $1,146 dollars (2014 constant U.S. dollars) per individual. The estimated saving was equivalent to 8.7% of overall health care expenditure in the preceding year of individuals receiving any mental health services ($13,141). Compared with the average cost of mental health services in the preceding year, which was $5,098 (i.e., the difference in average overall expenditures between individuals who used mental health services and those who did not), the estimated saving of $1,146 dollars was about 22.5% of the cost incurred for mental health care. Because mental health problems are common among adults with chronic physical conditions but often go unrecognized and thus left untreated, our study suggests a potential impact on health care expenditures of integrating mental health services for these individuals.

Adding to the current literature, our results also imply a greater financial benefit of providing a combination of psychotherapy and medication treatment for individuals with chronic physical conditions. The combination of psychotherapy and medication treatment subsequently lowered the increase of overall health care cost by 21.7 percentage points or $2,690 dollars for these adults. Previous studies have also found that the combination of psychotherapy and antidepressants was associated with a decrease in total health care expenditure among diabetes patients (22, 23, 41, 42) or was cost-effective for CVD patients (25).

We did not find a statistically significant impact of mental health service use on costs for inpatient services, outpatient services, and ED visits, which might be attributable to a short follow-up time. Some studies have suggested that cost reduction related to mental health care could result in a longer follow-up time (23, 25). Nevertheless, we found subsequent cost savings for office-based visits and prescribed medication among adults who used mental health services. Some studies suggested that cost containment associated with mental health services could be attributable to either reduction of future cost related to mental health conditions (43) or a decrease in future health care use resulting from improved chronic physical conditions (44).

Our findings may also speak to potential cost savings from health care delivery transformations rapidly expanding nationwide that integrate general medical and mental health care. Some health care delivery models with such integration have been shown to improve management of chronic illnesses, depression screening, and follow-up (45) while controlling cost growth (46, 47). Although our results suggest that providing mental health services, especially psychotherapy, may reduce overall costs for people with costly chronic physical conditions, they do not exclude the possibility that covering mental health services for the entire insured population will also in the long run reduce overall costs and increase quality of life. Future research is needed to investigate how state and federal policies that encourage behavioral health integration through delivery system reforms affect health care costs and health outcomes.

Our study had some limitations. First, given the nature of the MEPS, we were not able to investigate the impact on health care expenditures of receipt of mental health care in a longer follow-up time. Second, the data did not allow for separation of expenditures for physical conditions and mental health conditions. Also, because of the high prevalence of comorbidities in the study population, it was not possible to examine the impact of mental health services utilization separately for each chronic physical condition. Further studies may benefit from examining how mental health care influences costs for patients with chronic physical illnesses in the long-term, as well as examining separate costs for each physical condition and mental health conditions. Third, this was an observational study with 2 years of follow-up, and our estimates might be biased because of different trends in health care costs between the two groups (those who used mental health services and those who did not) during the pre-period. Although matching two groups by using inverse-probability weights could mitigate this concern by minimizing observed differences between the groups, and the application of the quasi-experimental DID approach possibly captured unobservable group differences, potential selection bias might not be completely ruled out with observational data. Finally, demand for mental health services could depend on prices and availability of services. Because of data limitations, we could not control for some state-level characteristics, such as state policy regarding mental health treatment or prices of mental health services.

Conclusions

Utilization of mental health services was associated with reduced overall health care expenditure among adults with major chronic physical conditions, including CVD, cancer, diabetes, emphysema, asthma, and arthritis. Psychotherapy alone had a larger effect on cost containment than did medication treatment alone—indeed the latter did not appear to have a meaningful effect on overall costs. The combination of the two, however, yielded a modestly larger effect than did psychotherapy alone. Future research should evaluate whether emerging health care delivery models that integrate general medical and mental health care are cost-effective.

Center for Healthcare Organizational and Innovation Research, University of California, Berkeley, and Sutter Health Center for Health Systems Research, Berkeley (Bui); Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland (Yoon); Health Management and Policy, College of Public Health and Human Sciences, and Health Data and Informatics, Center for Genome Research and Biocomputing, Oregon State University, Corvallis, and Center to Improve Veteran Involvement in Care, U.S. Department of Veterans Affairs Portland Healthcare System, Portland (Hynes)
Send correspondence to Dr. Bui ().

Preliminary results of this study were presented at the Behavioral Health Services Research Interest Group Pre-Conference Session, AcademyHealth Annual Research Meeting, Seattle, June 23–26, 2018.

The contents, views, and opinions expressed in this article are those of the authors and do not necessarily reflect official policy or position of the Uniformed Services University of the Health Sciences, the Department of Defense, or Departments of the Army, Navy, or Air Force.

The authors report no financial relationships with commercial interests.

References

1. Health, United States, 2016: With Chartbook on Long-Term Trends in Health. Hyattsville, MD, National Center for Health Statistics, 2017Google Scholar

2. At A Glance 2016: Improving the Quality of Life for People With Arthritis. Atlanta, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 2017Google Scholar

3. Mozaffarian D, Benjamin EJ, Go AS, et al.: Executive summary: heart disease and stroke statistics 2016 update: a report from the American Heart Association. Circulation 2016; 133:447–454Google Scholar

4. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, Centers for Disease Control and Prevention, 2014Google Scholar

5. Ford ES, Murphy LB, Khavjou O, et al.: Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest 2015; 147:31–45Crossref, MedlineGoogle Scholar

6. Barbour KE, Helmick CG, Boring M, et al.: Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation, United States, 2013–2015. MMWR Morb 2017; 66:246–253MedlineGoogle Scholar

7. Cancer Statistics. Bethesda, MD, National Cancer Institute, 2020. http://www.cancer.gov/about-cancer/understanding/statistics. Accessed May 26, 2016Google Scholar

8. Guthrie E: Emotional disorder in chronic illness: psychotherapeutic interventions. Br J Psychiatry 1996; 168:265–273Crossref, MedlineGoogle Scholar

9. Mayou R, Hawton K, Feldman E, et al.: Psychiatric problems among medical admissions. Int J Psychiatry Med 1991; 21:71–84Crossref, MedlineGoogle Scholar

10. Mikkelsen RL, Middelboe T, Pisinger C, et al.: Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD): a review. Nord J Psychiatry 2004; 58:65–70Crossref, MedlineGoogle Scholar

11. Celano CM, Huffman JC: Depression and cardiac disease: a review. Cardiol Rev 2011; 19:130–142Crossref, MedlineGoogle Scholar

12. McCabe PJ: Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs 2010; 25:40–51Crossref, MedlineGoogle Scholar

13. Rutledge T, Reis VA, Linke SE, et al.: Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48:1527–1537Crossref, MedlineGoogle Scholar

14. Magyar-Russell G, Thombs BD, Cai JX, et al.: The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 2011; 71:223–231Crossref, MedlineGoogle Scholar

15. Coping With Cancer: Feelings and Cancer. Bethesda, MD, National Cancer Institute, 2017. http://www.cancer.gov/about-cancer/coping. Accessed July 26, 2017Google Scholar

16. Leung YW, Flora DB, Gravely S, et al.: The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom Med 2012; 74:786–801Crossref, MedlineGoogle Scholar

17. de Jonge P, Honig A, van Melle JP, et al.: Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007; 164:1371–1378LinkGoogle Scholar

18. Carney RM, Blumenthal JA, Freedland KE, et al.: Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004; 66:466–474Crossref, MedlineGoogle Scholar

19. Roest AM, Martens EJ, Denollet J, et al.: Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010; 72:563–569Crossref, MedlineGoogle Scholar

20. Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25:464–470Crossref, MedlineGoogle Scholar

21. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160:3278–3285Crossref, MedlineGoogle Scholar

22. Bhattacharya R, Shen C, Wachholtz AB, et al.: Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression. BMC Psychiatry 2016; 16:247Crossref, MedlineGoogle Scholar

23. Simon GE, Katon WJ, Lin EH, et al.: Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007; 64:65–72Crossref, MedlineGoogle Scholar

24. Chen PC, Chan YT, Chen HF, et al.: Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care 2013; 36:376–382Crossref, MedlineGoogle Scholar

25. Celano CM, Healy B, Suarez L, et al.: Cost-effectiveness of a collaborative care depression and anxiety treatment program in patients with acute cardiac illness. Value Health 2016; 19:185–191Crossref, MedlineGoogle Scholar

26. Weinberger MI, Bruce ML, Roth AJ, et al.: Depression and barriers to mental health care in older cancer patients. Int J Geriatr Psychiatry 2011; 26:21–26Crossref, MedlineGoogle Scholar

27. Turner J, Kelly B: Emotional dimensions of chronic disease. West J Med 2000; 172:124–128Crossref, MedlineGoogle Scholar

28. Yoon J, Bernell SL: The role of adverse physical health events on the utilization of mental health services. Health Serv Res 2013; 48:175–194Crossref, MedlineGoogle Scholar

29. Medical Expenditure Panel Survey. Rockville, MD, Agency for Healthcare Research and Quality. https://meps.ahrq.gov/mepswebGoogle Scholar

30. MEPS Topics: Priority Conditions–General. Rockville, MD, Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2019. https://meps.ahrq.gov/mepsweb/data_stats/MEPS_topics.jsp?topicid=41Z-1Google Scholar

31. Using Appropriate Price Indices for Analyses of Health Care Expenditures or Income Across Multiple Years. Rockville, MD, Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2018. https://meps.ahrq.gov/about_meps/Price_Index.shtml. Accessed May 2019Google Scholar

32. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34:220–233Crossref, MedlineGoogle Scholar

33. Deb P, Norton EC, Manning WG: Health Econometrics Using Stata. College Station, TX, Stata Press, 2017Google Scholar

34. Dow WH, Norton EC: Choosing between and interpreting the Heckit and two-part models for corner solutions. Health Serv Outcomes Res Methodol 2003; 4:5–18CrossrefGoogle Scholar

35. Belotti F, Deb P, Manning WG, et al.: twopm: two-part models. Stata J 2015; 15:3–20CrossrefGoogle Scholar

36. Cattaneo MD: Efficient semiparametric estimation of multi-valued treatment effects under ignorability. J Econom 2010; 155:138–154CrossrefGoogle Scholar

37. Imbens G, Rubin DB: Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction. Cambridge, United Kingdom, Cambridge University Press, 2015CrossrefGoogle Scholar

38. Alberto A: Semiparametric difference-in-differences estimators. Rev Econ Stud 2005; 72:1CrossrefGoogle Scholar

39. Stuart EA, Huskamp HA, Duckworth K, et al.: Using propensity scores in difference-in-differences models to estimate the effects of a policy change. Health Serv Outcomes Res Methodol 2014; 14:166–182Crossref, MedlineGoogle Scholar

40. Stata Statistical Software: Release 13. College Station, TX, StataCorp, 2013Google Scholar

41. Katon W, Unützer J, Fan M-Y, et al.: Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006; 29:265–270Crossref, MedlineGoogle Scholar

42. Katon WJ, Russo JE, Von Korff M, et al.: Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care 2008; 31:1155–1159Crossref, MedlineGoogle Scholar

43. Kaplan RM, Glassman JR, Milstein A: Effects of mental health on the costs of care for chronic illnesses. Psychiatr Serv 2019; 70:1013–1019LinkGoogle Scholar

44. Jacob V, Chattopadhyay SK, Sipe TA, et al.: Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med 2012; 42:539–549Crossref, MedlineGoogle Scholar

45. Oregon Health System Transformation: CCO Metrics 2016 Final Report. Salem, Oregon Health Authority, 2017Google Scholar

46. McConnell KJ, Renfro S, Lindrooth RC, et al.: Oregon’s Medicaid reform and transition to global budgets were associated with reductions in expenditures. Health Aff 2017; 36:451–459CrossrefGoogle Scholar

47. McConnell KJ, Renfro S, Chan BKS, et al.: Early performance in Medicaid accountable care organizations: a comparison of Oregon and Colorado. JAMA Intern Med 2017; 177:538–545Crossref, MedlineGoogle Scholar